Leerink Partnrs Has Strong Estimate for TVTX FY2026 Earnings
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Analysts at Leerink Partnrs raised their FY2026 EPS estimates for shares of Travere Therapeutics in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will earn $0.63 per share for the year, up from their prior […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Analysts at Leerink Partnrs raised their FY2026 EPS estimates for shares of Travere Therapeutics in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will earn $0.63 per share for the year, up from their prior […]
